SAHPRA Tag

The South African Health Products Regulatory Authority (SAHPRA) invites industry stakeholders to attend a webinar on Strengthening Regulatory Oversight Through Improved Manufacturer Visibility.   The webinar will provide an overview of SAHPRA's initiatives aimed at enhancing regulatory oversight through improved visibility of manufacturers and associated suppliers across...

The South African Health Products Regulatory Authority (SAHPRA) invited industry stakeholders to attend a Webinar on the Updates to the Variations Guideline and Codes.   The webinar aimed to inform stakeholders of the updates to the Variations Guideline and associated codes, and to provide guidance on...

Pretoria, 08 July 2026 – The South African Pharmacy Council (SAPC), Health Professions Council of South Africa (HPCSA) and the South African Health Products Regulatory Authority (SAHPRA) hereby warn the public, pharmacies and dispensing medical practitioners against any continued use, prescription and/or dispensing of iDEXIS...

The South African Health Products Regulatory Authority (SAHPRA) hosted a webinar on the Introduction of Import Authorisation Requirements for Health Products Importers.   As part of aligning with WHO Global Benchmarking Tool (GBT) Maturity Level 3 (ML3), the SAHPRA is introducing a mandatory Import Authorisation System for all health...

The South African Health Products Regulatory Authority (SAHPRA) hosted the Regulatory Technical Forum (RTF) Meeting. Areas of discussion on the agenda included: Veterinary Medicines Medical devices & IVDs Complementary medicines Medicines (Allopathic) Inspectorate Updates Inspectorate and Regulatory Compliance Legislation/Guidelines for Comment/Implementation IT Upgrade   Download Presenatations   Recording ...

Pretoria, 23 May 2026 – The South African Health Products Regulatory Authority (SAHPRA), in collaboration with the South African Pharmacy Council (SAPC), has intensified enforcement action against the unlawful manufacturing and distribution of unregistered GLP-1 and GIP medicines containing either Semaglutide, Tirzepatide, or a combination...

The South African Health Products Regulatory Authority (SAHPRA) hosted a stakeholder engagement webinar focused on medical device licensing and compliance requirements. The purpose of the engagement was to provide targeted training to industry stakeholders on SAHPRA’s regulatory requirements, supporting improved compliance and effective implementation across the...